# Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)

> **NCT02021123** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Obesity Morbid

## Interventions

- **DRUG:** Anidulafungin 100mg single dose iv

## Key facts

- **NCT ID:** NCT02021123
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02021123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02021123, "Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02021123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*